Registered number
SC673513
CHELTPHARM LTD
Filleted Accounts
30 September 2025
CHELTPHARM LTD
Registered number: SC673513
Balance Sheet
as at 30 September 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 19,453 22,886
Current assets
Stocks 15,223 19,747
Debtors 4 25,314 11,721
Cash at bank and in hand 22,813 12,120
63,350 43,588
Creditors: amounts falling due within one year 5 (60,667) (35,789)
Net current assets 2,683 7,799
Total assets less current liabilities 22,136 30,685
Creditors: amounts falling due after more than one year 6 - (28,000)
Net assets 22,136 2,685
Capital and reserves
Called up share capital 100 100
Profit and loss account 22,036 2,585
Shareholder's funds 22,136 2,685
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Farhana Ashad
Director
Approved by the board on 14 May 2026
CHELTPHARM LTD
Notes to the Accounts
for the year ended 30 September 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 8 4
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 October 2024 27,500
At 30 September 2025 27,500
Depreciation
At 1 October 2024 4,614
Charge for the year 3,433
At 30 September 2025 8,047
Net book value
At 30 September 2025 19,453
At 30 September 2024 22,886
4 Debtors 2025 2024
£ £
VAT 19,007 5,414
Other debtors 6,307 6,307
25,314 11,721
5 Creditors: amounts falling due within one year 2025 2024
£ £
Trade creditors 41,451 30,858
Director loan 325 246
Taxation and social security costs 18,891 4,685
60,667 35,789
6 Creditors: amounts falling due after one year 2025 2024
£ £
Other creditors - 28,000
7 Other information
CHELTPHARM LTD is a private company limited by shares and incorporated in England. Its registered office is:
37 Castle Avenue
Edinburgh
Scotland
EH12 7LB
CHELTPHARM LTD SC673513 false 2024-10-01 2025-09-30 2025-09-30 VT Final Accounts February 2026 Farhana Ashad No description of principal activity SC673513 2023-10-01 2024-09-30 SC673513 core:WithinOneYear 2024-09-30 SC673513 core:AfterOneYear 2024-09-30 SC673513 core:ShareCapital 2024-09-30 SC673513 core:RetainedEarningsAccumulatedLosses 2024-09-30 SC673513 2024-10-01 2025-09-30 SC673513 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 SC673513 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 SC673513 bus:Director40 2024-10-01 2025-09-30 SC673513 core:PlantMachinery 2024-10-01 2025-09-30 SC673513 countries:England 2024-10-01 2025-09-30 SC673513 bus:FRS102 2024-10-01 2025-09-30 SC673513 bus:FilletedAccounts 2024-10-01 2025-09-30 SC673513 2025-09-30 SC673513 core:WithinOneYear 2025-09-30 SC673513 core:AfterOneYear 2025-09-30 SC673513 core:ShareCapital 2025-09-30 SC673513 core:RetainedEarningsAccumulatedLosses 2025-09-30 SC673513 core:PlantMachinery 2025-09-30 SC673513 2024-09-30 SC673513 core:PlantMachinery 2024-09-30 iso4217:GBP xbrli:pure